In April 2026, Dr. Nate Komer, a doctor of physical therapy, presented a detailed look at gait and Parkinson’s disease (PD) for a Northwest Parkinson’s Foundation (NWPF) webinar. Gait changes are among the most common and consequential effects of PD, and understanding what causes them is important for addressing them. For people living with PD, walking and gait require attention and effort. For most of those without PD, walking is done without thinking.
… Full Story>
In April 2026, the Parkinson’s Foundation hosted an expert briefing titled “Inside the Science: Parkinson’s Research Today.” Laurie Sanders, PhD, associate professor of neurology at Duke University, shared why she and many of her colleagues are increasingly optimistic about the direction of Parkinson’s disease research. Dr. Sanders focused on three key research areas — alpha-synuclein, mitochondrial function, and neuroinflammation — and explained how these pathways are now understood to be interconnected, opening new doors for disease-modifying therapies. This was a technical webinar. If this talk taught me anything, it’s that Parkinson’s disease is far more complex than most of us realize. I found myself looking up terms throughout — so consider this my best attempt at summarizing the science.
… Full Story>
Meditation for Young-Onset Parkinson’s Disease
A FREE four-week workshop specifically designed for people living with young-onset Parkinson’s disease (YOPD) and their care partners.
… Full Story>
Vision problems are among the most common — and most under-discussed — symptoms in Parkinson’s disease, affecting everything from reading and screen use to balance and driving safety. In early April, PMD Alliance hosted a webinar in which movement disorder specialist and neuro-ophthalmologist Dr. Shahnaz Miri answered vision questions submitted by people living with Parkinson’s. She was joined by Dr. Scott Sorenson, an ophthalmology resident, who provided a talk at dry eye disease.
… Full Story>
Volunteers are needed for a Stanford imaging research study on glutathione levels. Glutathione is an antioxidant naturally made by the body that is important for protecting cells from oxidative damage. Its levels have been shown to be reduced in Parkinson’s, but there is currently no way to easily measure this in patients. The researchers hope to see if they can indirectly measure brain levels of glutathione using imaging scans. If you are 40-80 years old, have Parkinson’s OR are healthy without a neurological or psychiatric diagnosis, and can lie flat in a brain MRI scanner for up to 45 minutes, contact the study team.
… Full Story>